DG vs STRO
Dollar General Corporation (DG) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DG currently screens at market cap $22.87B and trailing P/E 14.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DG and STRO stock pages for the full models.
Not investment advice.